We are live on ! Find out more
SK

Sarah Ketterer Causeway Capital Management

AUM $9.24B
1-Year Est. Return 21.27%
 

Sarah Ketterer is co-founder and CEO of Causeway Capital Management, a firm specializing in international and global value equities. Causeway is known for disciplined valuation work across developed and emerging markets. Ketterer’s commentary is often sought for perspective on non-U.S. equities, currencies, and relative value abroad.

This Fund
S&P 500
This Quarter Est. Return
+8.29%
1 Year Est. Return
+21.27%
3 Year Est. Return
+72.78%
5 Year Est. Return
+71.25%
10 Year Est. Return
+497.07%
AUM
$9.24B
AUM Growth
+$1.09B
Cap. Flow
+$508M
Cap. Flow %
5.5%
Top 10 Hldgs %
65.32%
Holding
129
New
22
Increased
49
Reduced
46
Closed
7

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$364M
2
DB icon
Deutsche Bank
DB
+$142M
3
CCL icon
Carnival Corporation Ltd
CCL
+$112M
4
NTES icon
NetEase
NTES
+$67.6M
5
BSX icon
Boston Scientific
BSX
+$39.1M

Top Sells

Rank Stock Value
1
CP icon
Canadian Pacific Kansas City
CP
+$178M
2
WHR icon
Whirlpool
WHR
+$64.8M
3
CTSH icon
Cognizant
CTSH
+$53.2M
4
APTV icon
Aptiv
APTV
+$47.5M
5
BP icon
BP
BP
+$41.8M

Sector Composition

Rank Sector Weight
1 Healthcare 25.55%
2 Consumer Discretionary 22.18%
3 Financials 19.31%
4 Industrials 12.93%
5 Technology 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDA icon
101
NVIDIA
NVDA
$5.2T
$714K 0.01%
3,567
-22
-0.6% -$4.52K
SCZ icon
102
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
$584K 0.01%
7,100
– –
INTR icon
103
Inter&Co
INTR
$2.38B
$546K 0.01%
+100,618
New +$676K
ORLA
104
DELISTED
Orla Mining
ORLA
$509K 0.01%
+52,100
New +$693K
SHG icon
105
Shinhan Financial Group
SHG
$35B
$417K ﹤0.01%
6,594
-246,982
-97% -$16.2M
GSK icon
106
GSK
GSK
$105B
$375K ﹤0.01%
7,163
-3,947
-36% -$209K
BTG icon
107
B2Gold
BTG
$7.29B
$354K ﹤0.01%
94,491
– –
LRCX icon
108
Lam Research
LRCX
$393B
$354K ﹤0.01%
+816
New +$248K
FIX icon
109
Comfort Systems
FIX
$58.3B
$321K ﹤0.01%
162
-22
-12% -$39.9K
RNR icon
110
RenaissanceRe
RNR
$13.4B
$315K ﹤0.01%
994
– –
AVGO icon
111
Broadcom
AVGO
$1.75T
$303K ﹤0.01%
802
-41
-5% -$16.4K
TRMD icon
112
TORM
TRMD
$3.26B
$290K ﹤0.01%
+11,244
New +$341K
AAPL icon
113
Apple
AAPL
$4.51T
$274K ﹤0.01%
947
+24
+3% +$6.87K
INMD icon
114
InMode
INMD
$867M
$266K ﹤0.01%
18,180
-53,649
-75% -$749K
ALL icon
115
Allstate
ALL
$64.2B
$263K ﹤0.01%
1,107
+102
+10% +$22.2K
B
116
Barrick Mining
B
$78.3B
$256K ﹤0.01%
6,966
-770
-10% -$31.6K
PDS
117
Precision Drilling
PDS
$1.18B
$253K ﹤0.01%
3,291
– –
NVS icon
118
Novartis
NVS
$302B
$235K ﹤0.01%
1,501
+14
+0.9% +$2.1K
SLM icon
119
SLM Corp
SLM
$4.97B
$228K ﹤0.01%
+8,774
New +$198K
MSFT icon
120
Microsoft
MSFT
$3.59T
$224K ﹤0.01%
600
-172
-22% -$69.6K
VICI icon
121
VICI Properties
VICI
$29.2B
$212K ﹤0.01%
+7,985
New +$224K
INN
122
Summit Hotel Properties
INN
$664M
$120K ﹤0.01%
17,063
+2,225
+15% +$12.3K
APTV icon
123
Aptiv
APTV
$10B
– –
-683,463
Closed -$47.5M
EFXT
124
Enerflex
EFXT
$2.48B
– –
-52,946
Closed -$1.1M
PDD icon
125
Pinduoduo
PDD
$126B
– –
-237,010
Closed -$24.2M
2 3 4
5
6

Similar funds

CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
OPERF
Oregon Public Employees Retirement Fund Tigard, Oregon $9.26B AUM 42.17% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $9.19B AUM 25.65% 1-Year Est. Return
MU
Mirova US Boston, Massachusetts $9.3B AUM 25.54% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Sarah Ketterer's Q2 2026 Portfolio in Review

As of Q2 2026, Sarah Ketterer held 129 positions worth $9.24B, up 13% from $8.15B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Sarah Ketterer deployed $508M of net new capital in Q2 2026, opening 22 new positions and adding to 49 existing holdings. Its largest new stake was NetEase: 572,412 shares worth $73.3M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Canadian Pacific Kansas City, an estimated $178M trimmed.

  • Sarah Ketterer's largest Q2 2026 buy was NetEase: 572,412 shares worth $73.3M.
  • Sarah Ketterer added most to AstraZeneca in Q2 2026, an estimated $364M increase.
  • Sarah Ketterer's biggest Q2 2026 reduction was Canadian Pacific Kansas City, cutting an estimated $178M.
  • Sarah Ketterer fully exited Whirlpool in Q2 2026, selling an estimated $64.8M.
  • Sarah Ketterer's ten largest holdings make up 65% of its $9.24B portfolio in Q2 2026.
  • Sarah Ketterer opened 22 new positions and closed 7 in Q2 2026.
  • Sarah Ketterer's portfolio value rose 13% quarter-over-quarter to $9.24B.

Based on Causeway Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.